Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001562180-24-001992

CEO and President sold 37,733 shares at $1.52 ($57,354)

From the SEC's structured data for this filing

Trades in this filing

Butler John P. · CEO and President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-02-27 Sale : show line 1 in the form −37,733 $1.52 $57,354 2,091,150 D
Open-market sales · 37,733 sh · avg $1.52 · $57,354
Loading xslF345X05/primarydocument.xml…